Upregulated LINC00665 was also significantly associated with lower disease-free survival in patients with multiple cancers, including breast cancer [11], prostate cancer [16], ovarian cancer [17], cholangiocarcinoma [8], non-small cell lung cancer [7], and lung adenocarcinoma [1]. This evidence concerns the gene LINC00665 and ovarian carcinoma.